Tumor associated antigen
Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe
13
The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells
11
The tumor associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells
21
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
10
Apoptotic function of tumor associated antigen RCAS1 in oral squamous cell carcinoma
10
Tumor-associated antigen CAPER and microvessel density in hepatocellular carcinoma
11
New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
11
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.
10
Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation
18
Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES
12
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
18
Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report
5
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
18
Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen
10
T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression
127
In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
6
Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens
11
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
13
Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration
12
Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73-kilodalton heat shock protein.
6